摘要
临床前安全性研究的不规范性会影响药品的科学评价。GLP有利于增进药品技术审评的科学化与规范化,而药品技术审评有助于促进GLP的实施与完善。二者应协调发展、与时俱进,相得益彰,提高我国的新药研发水平,促进医药产业的发展,保障人民健康。
Absence of standardization in pre-clinical safety study will influence the scientific evaluation of drugs, while implementation of GLP will facilitate scientific and standardized technical evaluation of drugs. On the other hand, drug technical evaluation will, also promote the implementation and improvement of GLP. We should develop these two in phase and continuously so as to bring out the best in each other, and thus improve level of drug research, advance development of pharmaceutical industry, and guarantee the safety and efficacy of drugs.
出处
《中国药事》
CAS
2005年第7期390-392,共3页
Chinese Pharmaceutical Affairs
关键词
GLP
药品技术审评
GLP
technical evaluation for drugs
